3320

COM:CRPHARM

华润医药集团有限公司

  • Stock

Last Close

5.33

22/11 08:08

Market Cap

34.24B

Beta: -

Volume Today

12.67M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
116.95B
-
135.75B
16.07%
146.57B
7.97%
156.71B
6.92%
172.53B
10.10%
189.69B
9.94%
204.45B
7.78%
200.42B
1.97%
236.81B
18.15%
254.11B
7.31%
244.70B
3.70%
cost of revenue
96.80B
-
114.26B
18.03%
123.37B
7.97%
132.60B
7.48%
144.26B
8.79%
154.76B
7.28%
170.44B
10.13%
168.13B
1.35%
201.43B
19.80%
214.97B
6.72%
206.37B
4.00%
gross profit
20.15B
-
21.49B
6.66%
23.20B
7.95%
24.11B
3.92%
28.28B
17.28%
34.93B
23.53%
34.02B
2.61%
32.29B
5.07%
35.38B
9.56%
39.13B
10.61%
38.34B
2.04%
selling and marketing expenses
8.42B
-
8.80B
4.48%
10.11B
14.90%
10.95B
8.27%
13.87B
26.68%
18.34B
32.25%
19.19B
4.62%
16.03B
16.46%
17.53B
9.37%
19.03B
8.57%
general and administrative expenses
3.67B
-
4.25B
15.61%
3.84B
9.46%
3.88B
0.97%
4.20B
8.23%
4.70B
11.94%
5.20B
10.63%
5.56B
6.91%
6.24B
12.10%
6.48B
3.89%
selling general and administrative expenses
12.10B
-
13.05B
7.86%
13.96B
6.97%
14.83B
6.26%
18.12B
22.16%
23.13B
27.70%
24.84B
7.37%
22.51B
9.39%
23.77B
5.61%
25.51B
7.34%
25.51B
0.03%
research and development expenses
730.62M
-
944.79M
29.31%
781.14M
17.32%
789.42M
1.06%
908.18M
15.04%
1.04B
14.44%
1.15B
11.07%
1.32B
14.18%
2.07B
-
other expenses
304.30M
-
43.57M
85.68%
-211.80M
586.10%
311.62M
247.13%
451.39M
44.85%
467.25M
3.51%
706.10M
51.12%
-558.49M
179.10%
-564.99M
1.16%
-464.44M
17.80%
cost and expenses
108.90B
-
127.31B
16.90%
136.66B
7.35%
146.90B
7.50%
162.13B
10.37%
178.03B
9.80%
196.43B
10.34%
191.95B
2.28%
224.63B
17.02%
240.02B
6.85%
233.94B
2.53%
operating expenses
12.10B
-
13.05B
7.86%
13.29B
1.85%
14.31B
7.68%
17.88B
24.94%
23.27B
30.16%
25.99B
11.70%
23.82B
8.35%
23.20B
2.61%
25.05B
7.95%
27.58B
10.10%
interest expense
1.77B
-
2.13B
20.55%
2.09B
2.00%
1.83B
12.47%
2.27B
23.81%
2.94B
29.65%
3.72B
26.47%
3.16B
15.05%
2.74B
13.08%
2.85B
3.98%
2.39B
16.21%
ebitda
9.71B
-
10.20B
5.09%
9.15B
10.36%
9.51B
3.93%
10.74B
12.97%
11.96B
11.38%
10.39B
13.14%
10.91B
5.05%
14.54B
33.22%
16.50B
13.45%
13.92B
15.60%
operating income
8.51B
-
8.85B
3.96%
7.88B
10.98%
8.32B
5.63%
9.29B
11.59%
10.44B
12.45%
8.02B
23.17%
8.47B
5.56%
11.72B
38.35%
13.34B
13.88%
10.76B
19.37%
depreciation and amortization
1.20B
-
1.35B
13.14%
1.27B
6.31%
1.18B
6.67%
1.45B
22.72%
1.52B
4.52%
2.36B
55.85%
2.44B
3.35%
2.82B
15.46%
3.15B
11.70%
3.16B
0.39%
total other income expenses net
-1.60B
-
-1.93B
20.44%
171.03M
108.87%
-280.27M
263.87%
-705.15M
151.60%
-1.26B
78.93%
-1.53B
20.91%
-1.60B
5.00%
-3.31B
106.65%
-3.49B
5.40%
-1.30B
62.84%
income before tax
6.91B
-
6.92B
0.14%
8.05B
16.29%
8.04B
0.09%
8.58B
6.71%
9.18B
6.99%
6.50B
29.22%
6.87B
5.69%
8.41B
22.42%
9.86B
17.21%
9.46B
3.98%
income tax expense
1.46B
-
1.43B
1.88%
1.97B
37.54%
2.07B
5.41%
1.72B
17.31%
1.61B
6.14%
1.54B
4.25%
1.75B
13.63%
1.76B
0.52%
2.01B
14.27%
2.11B
4.61%
net income
2.64B
-
2.65B
0.24%
2.85B
7.72%
2.82B
1.01%
3.48B
23.45%
4.04B
15.93%
3.29B
18.61%
3.30B
0.33%
6.65B
101.61%
7.84B
17.99%
3.85B
50.86%
weighted average shs out
6.17B
-
6.17B
0%
4.63B
25.00%
4.91B
6.11%
6.28B
27.93%
6.28B
0%
6.28B
0%
6.28B
0.02%
6.28B
0.01%
6.28B
0%
6.28B
0%
weighted average shs out dil
6.17B
-
6.17B
0%
4.63B
25.00%
4.91B
6.11%
6.28B
27.93%
6.28B
0%
6.28B
0%
6.28B
0.02%
6.28B
0.01%
6.28B
0%
6.28B
0%
eps
0.43
-
0.43
0%
0.62
44.19%
0.57
8.06%
0.55
3.51%
0.64
16.36%
0.52
18.75%
0.52
0%
1.06
103.85%
1.25
17.92%
0.61
51.20%
epsdiluted
0.43
-
0.43
0%
0.62
44.19%
0.57
8.06%
0.55
3.51%
0.64
16.36%
0.52
18.75%
0.52
0%
1.06
103.85%
1.25
17.92%
0.61
51.20%

All numbers in (except ratios and percentages)